Effect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report

Kentaro Matsui,1,2 Yoshikazu Takaesu,2,3 Takeshi Inoue,3 Ken Inada,1 Katsuji Nishimura1 1Department of Psychiatry, Tokyo Women’s Medical University, 2Japan Somnology Center, Neuropsychiatric Research Institute, 3Department of Psychiatry, Tokyo Medical University, Tokyo, Japan Background:...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Matsui K, Takaesu Y, Inoue T, Inada K, Nishimura K
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/622bf5337420400e9db12bb713ebf188
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:622bf5337420400e9db12bb713ebf188
record_format dspace
spelling oai:doaj.org-article:622bf5337420400e9db12bb713ebf1882021-12-02T04:58:10ZEffect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report1178-2021https://doaj.org/article/622bf5337420400e9db12bb713ebf1882017-05-01T00:00:00Zhttps://www.dovepress.com/effect-of-aripiprazole-on-non-24-hour-sleep-wake-rhythm-disorder-comor-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Kentaro Matsui,1,2 Yoshikazu Takaesu,2,3 Takeshi Inoue,3 Ken Inada,1 Katsuji Nishimura1 1Department of Psychiatry, Tokyo Women’s Medical University, 2Japan Somnology Center, Neuropsychiatric Research Institute, 3Department of Psychiatry, Tokyo Medical University, Tokyo, Japan Background: Patients with non-24-hour sleep–wake rhythm disorder (N24SWD) exhibit a sleep pattern that is asynchronous with the external light–dark cycle, typically involving a cycling, relapsing–remitting pattern of sleep disturbances, including nighttime insomnia and daytime sleepiness. Here, we report the case of a patient with N24SWD comorbid with major depressive disorder, who was successfully treated with a low dose of aripiprazole.Case presentation: A 47-year-old female presented with an 8-year complaint of difficulty falling asleep and waking up in the morning. The patient was diagnosed with major depressive disorder at the age of 35 years and was treated with various antidepressants since that time. At the age of 40 years, the patient’s sleep–wake cycle began to extend without exacerbation of depressive symptoms. The patient was diagnosed with N24SWD at the age of 43 years. Ramelteon 8 mg/d and then melatonin 1 mg/d were administered, but these did not provide effective treatment. In January 2016, after treatment with aripiprazole 3 mg/d in the morning for 4 weeks, the patient’s sleep–wake cycle became markedly synchronized to the environmental light–dark cycle. Her sleep–wake cycle remained synchronized when the same dose of aripiprazole was administered for at least 6 months.Conclusion: Treatment-refractory asynchrony of the sleep–wake cycle in an N24SWD patient with depression was successfully treated with aripiprazole. Although the detailed mechanism of action is unclear, aripiprazole may be an appropriate treatment for patients with circadian rhythm sleep–wake disorders. Keywords: circadian rhythm sleep–wake disorder, non-24-hour sleep–wake rhythm disorder, melatonin, long sleep duration, antipsychoticMatsui KTakaesu YInoue TInada KNishimura KDove Medical Pressarticlecircadian rhythm sleep-wake disordernon-24-hour sleep-wake rhythm disorderaripiprazolelong sleep durationdepressionNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 1367-1371 (2017)
institution DOAJ
collection DOAJ
language EN
topic circadian rhythm sleep-wake disorder
non-24-hour sleep-wake rhythm disorder
aripiprazole
long sleep duration
depression
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle circadian rhythm sleep-wake disorder
non-24-hour sleep-wake rhythm disorder
aripiprazole
long sleep duration
depression
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Matsui K
Takaesu Y
Inoue T
Inada K
Nishimura K
Effect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report
description Kentaro Matsui,1,2 Yoshikazu Takaesu,2,3 Takeshi Inoue,3 Ken Inada,1 Katsuji Nishimura1 1Department of Psychiatry, Tokyo Women’s Medical University, 2Japan Somnology Center, Neuropsychiatric Research Institute, 3Department of Psychiatry, Tokyo Medical University, Tokyo, Japan Background: Patients with non-24-hour sleep–wake rhythm disorder (N24SWD) exhibit a sleep pattern that is asynchronous with the external light–dark cycle, typically involving a cycling, relapsing–remitting pattern of sleep disturbances, including nighttime insomnia and daytime sleepiness. Here, we report the case of a patient with N24SWD comorbid with major depressive disorder, who was successfully treated with a low dose of aripiprazole.Case presentation: A 47-year-old female presented with an 8-year complaint of difficulty falling asleep and waking up in the morning. The patient was diagnosed with major depressive disorder at the age of 35 years and was treated with various antidepressants since that time. At the age of 40 years, the patient’s sleep–wake cycle began to extend without exacerbation of depressive symptoms. The patient was diagnosed with N24SWD at the age of 43 years. Ramelteon 8 mg/d and then melatonin 1 mg/d were administered, but these did not provide effective treatment. In January 2016, after treatment with aripiprazole 3 mg/d in the morning for 4 weeks, the patient’s sleep–wake cycle became markedly synchronized to the environmental light–dark cycle. Her sleep–wake cycle remained synchronized when the same dose of aripiprazole was administered for at least 6 months.Conclusion: Treatment-refractory asynchrony of the sleep–wake cycle in an N24SWD patient with depression was successfully treated with aripiprazole. Although the detailed mechanism of action is unclear, aripiprazole may be an appropriate treatment for patients with circadian rhythm sleep–wake disorders. Keywords: circadian rhythm sleep–wake disorder, non-24-hour sleep–wake rhythm disorder, melatonin, long sleep duration, antipsychotic
format article
author Matsui K
Takaesu Y
Inoue T
Inada K
Nishimura K
author_facet Matsui K
Takaesu Y
Inoue T
Inada K
Nishimura K
author_sort Matsui K
title Effect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report
title_short Effect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report
title_full Effect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report
title_fullStr Effect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report
title_full_unstemmed Effect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report
title_sort effect of aripiprazole on non-24-hour sleep–wake rhythm disorder comorbid with major depressive disorder: a case report
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/622bf5337420400e9db12bb713ebf188
work_keys_str_mv AT matsuik effectofaripiprazoleonnon24hoursleepndashwakerhythmdisordercomorbidwithmajordepressivedisorderacasereport
AT takaesuy effectofaripiprazoleonnon24hoursleepndashwakerhythmdisordercomorbidwithmajordepressivedisorderacasereport
AT inouet effectofaripiprazoleonnon24hoursleepndashwakerhythmdisordercomorbidwithmajordepressivedisorderacasereport
AT inadak effectofaripiprazoleonnon24hoursleepndashwakerhythmdisordercomorbidwithmajordepressivedisorderacasereport
AT nishimurak effectofaripiprazoleonnon24hoursleepndashwakerhythmdisordercomorbidwithmajordepressivedisorderacasereport
_version_ 1718400954032717824